1Kyle RA, Yee GC, Somerfield MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Ctin Oncol, 2007, 25: 2464-2472.
2Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol, 2003, 21:4042-4057.
3Berry S, Waldron T, Winquist E, et al. The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials. Can J Urol, 2006,13:3180-3188.
4Brown JP, Josse RG. Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ, 2002, 167 (Suppl) : S 1 -S34.
5Dimopoulos MA, Kastritis E, Anagnostopoulos A, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates : Evidence of increased risk after treatment with zoledronic acid. Haematologica, 2006,91:968-971.
6Durie BG, Katz M, Crowley J. Osteonecrosis of the jaws and bisphosphonates. N Engl J Med, 2005,353:99-102.
7Hoff AO, Toth BB, Altundag K, et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. ASCO Annual Meeting Proceedings (post meeting edition). J Clin Oncol, 2006,24: 8528.
8Pozzi S, Marcheselli R, Sacchi S. Analysis of frequency and risk factors for developing bisphosphonate associated necrosis of the jaw. American Society of Hematology Annual Meeting [ abstract ]. Blood, 2005:5057.
9Tosi P, Zamagni E, Cangini D. Bisphosphonates and osteonecrosis of the jaws : Incidence in a homogeneous series of patien ts with newly diagnosed multiple myeloma treated with zoledronic acid. American Society of Hematology Annual Meeting [ abstract ]. Blood, 2005 : 3461.
10Zavras AI, Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis? J Oral Maxillofac Surg, 2006,64 : 917-923.
1Weiwei W,Xiaolin Z,Jiaqiang Z,et al.High glucosestimulates adipogenic and inhibits osteogenic differentia-tion in MG-63cells through cAMP/protein kinase A/ex-tracellular signal-regulated kinase pathway[J].2010,(7):82-84.
2Klingenstein GG, Yeager AM, Lipman JD, et al. Computerizedrange of motion analysis following dual mobility total hiparthroplasty, traditional total hip arthroplasty, and hipresurfacing. J Arthroplasty. 2013;28(7):1173-1176.
3Schiffern AN, Stevenson DA, Carroll KL, et al. Total hiparthroplasty, hip osteoarthritis, total knee arthroplasty, andknee osteoarthritis in patients with developmental dysplasia ofthe hip and their family members: A kinship analysis report. JPediatr Orthop. 2012;32(6):609-612.
